Dienstag, 21. Februar 2017


  • Pressemitteilung BoxID 154950

Appellate court upholds Fresenius SE annual general meeting resolutions on authorized capital

binding decision confirms final legal validity

(lifePR) (Bad Homburg, ) The resolutions on authorized capitals adopted by a large majority at Fresenius SE's annual general meeting on May 8, 2009, are final and binding. This results from the decision delivered today by the appellate court (Oberlandesgericht) in Frankfurt am Main, Germany, with regard to a judicial clearance proceeding (Freigabeverfahren) initiated by Fresenius. An appeal to a higher court is not available. As a consequence, the authorized capitals, which are already recorded in the commercial register, are definitively available.

The judicial clearance proceeding was prompted by legal challenges filed by two individual shareholders. The court's presiding division (Senat) upheld Fresenius SE's argument that the company's interest in implementing the resolutions outweighs the plaintiffs' interest in staying such implementation. The legal challenge underlying the decision is pending with the same court. However, this forthcoming decision has now become irrelevant with respect to the authorized capital resolutions covered by the clearance proceeding.

Authorized capital is commonly used by companies to maintain financial flexibility. Fresenius has currently no plans for a capital increase.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g., changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius AG (SE)

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care. In 2009, group sales were approximately €14.2 billion. On Dec. 31, 2009, the Fresenius Group had 130,510 employees worldwide.

For current information, visit the company's website at www.fresenius.com.

Diese Pressemitteilungen könnten Sie auch interessieren

Erfolgreiches Geschäftsjahr 2016 für die Sparkasse Bremen

, Finanzen & Versicherungen, Die Sparkasse Bremen AG

. Gewinn stieg deutlich auf über 32 Millionen Euro Klarer Marktführer in Bremen bei Privat- und Firmenkunden Auszeichnung als einer der besten...

MBB Clean Energy AG: Kaufangebot prüfen lassen

, Finanzen & Versicherungen, CLLB Rechtsanwälte Cocron, Liebl, Leitz, Braun, Kainz Partnerschaft mbB

Die Kanzlei CLLB Rechtsanwälte rät betroffenen Anlegern, das Kaufangebot der Value-Line Management GmbH nicht ohne vorherige Prüfung anzunehmen....

Achtung Immobilienblase: Aufsichtsrecht der BaFin soll für den Krisenfall gestärkt werden

, Finanzen & Versicherungen, ROSE & PARTNER LLP

Die Erinnerung an die Immobilienblase und deren Auswirkungen auf den Finanzmarkt im Jahr 2008 sind noch frisch. Um ein ähnliches Szenario zu...

Disclaimer